Form 13-F position report

CVS HEALTH CORPORATION (DE)

Reported by ADAMS DIVERSIFIED EQUITY FUND INC

CVS CUSIP 126650100 Manager CIK 0000002230

Reported 382,900 shares, unchanged from the prior quarter.

Reported value 21.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 1.5% This manager · Q4 2021
Shares 382,900 Quarter-end amount reported
Reported value $39,500,000 Fair value at quarter end
Consecutive quarters held 9 Through Q4 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 39500000
2022-03-31 32903000
2022-06-30 35674000
2022-09-30 36717000
2022-12-31 35878150
2023-03-31 19816545
2023-06-30 14764371
2023-09-30 0
2025-09-30 9612225
2025-12-31 27879168
2026-03-31 14414274
2026-06-30 20762415
2026-09-30 16675274

Quarterly position history

How this manager's reported quarter-end position changed over time.

13 quarters
Quarterly reported position history for CVS HEALTH CORPORATION (DE) held by ADAMS DIVERSIFIED EQUITY FUND INC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 194,600 -6,100 (-3.0%) 0.51% $16,675,274 2026-10-21
Q2 2026 Unchanged 200,700 0 (0.0%) 0.63% $20,762,415 2026-07-22
Q1 2026 Reduced 200,700 -150,600 (-42.9%) 0.51% $14,414,274 2026-04-22
Q4 2025 Added 351,300 +223,800 (175.5%) 0.93% $27,879,168 2026-02-13
Q3 2025 New 127,500 +127,500 (0.0%) 0.32% $9,612,225 2025-10-22
Q3 2023 Reduced 0 -213,574 (-100.0%) 0 $0 2023-10-25
Q2 2023 Reduced 213,574 -53,100 (-19.9%) 0.61% $14,764,371 2023-08-01
Q1 2023 Reduced 266,674 -118,326 (-30.7%) 0.89% $19,816,545 2023-04-26
Q4 2022 Unchanged 385,000 0 (0.0%) 1.72% $35,878,150 2023-02-03
Q3 2022 Unchanged 385,000 0 (0.0%) 1.83% $36,717,000 2022-10-26
Q2 2022 Added 385,000 +59,900 (18.4%) 1.69% $35,674,000 2022-07-27
Q1 2022 Reduced 325,100 -57,800 (-15.1%) 1.31% $32,903,000 2022-04-27
Q4 2021 Unchanged 382,900 0 (0.0%) 1.5% $39,500,000 2022-02-11
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2334 managers reported CVS HEALTH CORPORATION (DE) for Q4 2021.

Managers reporting CVS HEALTH CORPORATION (DE) in Q4 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 109,236,922 +879,616 0.26% $11,268,882,000 35 qtrs
BlackRock Inc Reduced 93,556,501 -1,038,447 0.25% $9,651,288,000 35 qtrs
STATE STREET CORPORATION Added 56,810,314 +1,560,168 0.28% $5,860,552,000 35 qtrs
Capital World Investors Reduced 50,102,110 -471,878 0.82% $5,168,570,000 10 qtrs
Capital International Investors Added 27,821,477 +414,724 0.61% $2,870,096,000 35 qtrs
MORGAN STANLEY Added 24,281,050 +1,431,615 0.31% $2,504,831,000 35 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 22,099,200 +408,181 0.27% $2,273,690,000 35 qtrs
JPMorgan Chase & Co Reduced 19,331,778 -848,033 0.23% $1,994,268,000 35 qtrs
Invesco Ltd Reduced 17,691,791 -319,776 0.44% $1,825,084,000 35 qtrs
Bank of America Corporation Added 17,308,556 +76,208 0.17% $1,785,549,000 35 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2021
Filed
February 11, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
382,900
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.